Antipsychotic Prochlorperazine Restrains Bladder Cancer Growth by Regulating cell proliferation and SRC-MEK-ERK Pathway

Author:

Lu Xiongbing1,Mei Jiaqi2,Hu Chao1,Li Jing3,He Yuanqiao4

Affiliation:

1. The Second Affiliated Hospital of Nanchang University

2. Nanchang University

3. University of South Carolina

4. Nanchang University, Nanchang University

Abstract

Abstract The high incidence of bladder cancer and inconvenient life quality prompt us to find new therapeutic candidates. Prochlorperazine, mainly as an effective sedative, antiemetic reagent, was shown to exhibit anti-cancer activity in several studies, putting it up as a therapeutic candidate for bladder cancer. Network pharmacologic approaches is a high valuable tool in predicting rational drug targets within disease signaling module. Network based protein-protein interactome prediction, GO annotation and KEGG pathway enrichment analysis showed that prochlorperazine might affect bladder cancer growth through multiple signaling pathways. Cellular function experiments revealed that prochorperazine inhibited cell proliferation in several bladder cancer cell lines and in vivo mouse xenograft test confirmed its significant inhibition effect on BC. Western blotting analysis demonstrated that prochlorperazine treatment markedly modulated the expression and phosphorylation levels of MAPK1(ERK2)、MAP2K1(MEK1)and SRC, showing the possible molecular mechanism via the SRC-MEK-ERK pathway in BC cancer. These studies indicated the potential inhibitory impact of prochlorperazine and provided new ideas for the pathogenesis and treatments of BC.

Publisher

Research Square Platform LLC

Reference22 articles.

1. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review;Otreba M;J Appl Toxicol,2021

2. High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response study;Carr BI;Cancer,1987

3. Effects of extracellular calmodulin and calmodulin antagonists on B16 melanoma cell growth;Mac Neil S;J Invest Dermatol,1984

4. Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines;Otreba M;Naunyn-Schmiedeberg's archives of pharmacology,2019

5. Perphenazine and prochlorperazine induce concentration-dependent loss in human glioblastoma cells viability;Otreba M;Die Pharmazie,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3